GoKawiil
31.
32.
33.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
34.
Novo Nordisk and OpenAI Partner to Speed Drug Discovery
(feeds.content.dowjones.io)
35.
Big Pharma Is Turning to China for the Newest Drug Ideas
(feeds.content.dowjones.io)
36.
37.
Daily briefing: AI spread information about an obviously made-up disease
(feeds.nature.com)
38.
Why obesity drugs work better for some people: these genes hold clues
(feeds.nature.com)
39.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
(feeds.nature.com)
40.
Metabolomics across scales: from single cells to population studies
(feeds.nature.com)
41.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
42.
New drugs take aim at one of cancer’s deadliest mutations
(feeds.nature.com)
43.
Peptides: where to begin?
(news.ycombinator.com)
44.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests
(feeds.feedburner.com)
45.
Neurocrine to Buy Soleno, Nabbing Drug for Relentless Hunger Disorder
(feeds.content.dowjones.io)
46.
Common drug tests lead to tens of thousands wrongful arrests a year
(news.ycombinator.com)
47.
48.
49.
Chatbots are now prescribing psychiatric drugs
(theverge.com)
50.
AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results
(feeds.content.dowjones.io)
51.
52.
Eli Lilly, InSilico Strike AI Drug Discovery Deal
(feeds.content.dowjones.io)
53.
55.
56.
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
57.
Eye drops made from pig semen deliver cancer treatment to mice
(feeds.nature.com)
58.
Towards intelligent and miniaturized drug delivery devices
(feeds.nature.com)
59.
Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says
(feeds.content.dowjones.io)